Overview
FDA & Trial Timeline
9 eventsMassachusetts Eye and Ear Infirmary — PHASE1
University College, London
Unity Health Toronto — PHASE2
Massachusetts Eye and Ear Infirmary — PHASE1, PHASE2
Cincinnati Eye Institute, Southwest Ohio — PHASE2
Unity Health Toronto — PHASE2
Wills Eye — PHASE2, PHASE3
Central Hospital, Nancy, France — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Vitreoretinopathy.
4 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Vitreoretinopathy.
Community
No community posts yet. Be the first to share your experience with Vitreoretinopathy.
Start the conversation →Latest news about Vitreoretinopathy
Disease timeline:
New recruiting trial: Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial
A new clinical trial is recruiting patients for Vitreoretinopathy
New recruiting trial: Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment
A new clinical trial is recruiting patients for Vitreoretinopathy
New recruiting trial: Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment with Proliferative Vitreoretinopathy
A new clinical trial is recruiting patients for Vitreoretinopathy
New recruiting trial: REtinal Detachment Outcomes Study
A new clinical trial is recruiting patients for Vitreoretinopathy
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Vitreoretinopathy
Are there clinical trials for Vitreoretinopathy?
Yes — 4 recruiting clinical trials are currently listed for Vitreoretinopathy on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Vitreoretinopathy?
14 specialists and care centers treating Vitreoretinopathy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.